Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram
- 1 January 2009
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 102 (11), 936-944
- https://doi.org/10.1160/th09-03-0180
Abstract
Elevated procoagulant levels have been correlated with increased thrombin generation in vitro and with increased venous thromboembolism (VTE) risk in epidemiological studies. hrombin generation tests are increasingly being employed as a high throughput method to provide a global measure of procoagulant activity in plasma samples. The objective of this study was to distinguish the effects of assay conditions [tissue factor (TF), thrombomodulin, platelets/lipids] and factor levels on thrombin generation parameters, and determine the conditions and parameters with the highest sensitivity and specificity for detecting elevated factor levels. Thrombin generation was measured using calibrated automated thrombography (CAT) in corn trypsin inhibitor (CTI)-treated platelet-free plasma (PFP) and plateletrich plasma (PRP). Statistical analysis was performed using logarithms of observed values with analysis of variance that accounted for experiment and treatment. he relative sensitivity of lag time (LT), time to peak (TTP), peak height and endogenous thrombin potential (ETP) to elevated factors XI, IX,VIII, X, and prothrombin was as follows: PFP initiated with 1 pM TF > PFP initiated with 5 pM TF > PRP initiated with 1 pM TF. For all conditions, inclusion of thrombomodulin prolonged the LT and decreased the peak and ETP; however, addition of thrombomodulin did not increase the ability of CAT to detect elevated levels of individual procoagulant factors. In conclusion, CAT conditions differentially affected the sensitivity of thrombin generation to elevated factor levels. Monitoring the peak height and/ or ETP following initiation of clotting in PFP with 1 pM TF was most likely to detect hypercoagulability due to increased procoagulant factor levels.Funding Information
- UNC Institute on Aging, Novo Nordisk, Gustavus and Louise Pfeiffer Research Foundation (NIH (K01AR051021), NSF (0705977))
This publication has 42 references indexed in Scilit:
- Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assayThrombosis Research, 2010
- High rate of unprovoked recurrent venous thrombosis is associated with high thrombin‐generating potential in a prospective cohort studyJournal of Thrombosis and Haemostasis, 2008
- Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosisJournal of Thrombosis and Haemostasis, 2008
- Thrombin generation in patients after acute deep-vein thrombosisThrombosis and Haemostasis, 2008
- Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasmaThrombosis and Haemostasis, 2008
- The risk of venous thrombosis associated with a high endogenous thrombin potential in the absence and presence of activated protein CJournal of Thrombosis and Haemostasis, 2007
- Elimination of contact factor activation improves measurement of platelet‐dependent thrombin generation by calibrated automated thrombography at low‐concentration tissue factorJournal of Thrombosis and Haemostasis, 2006
- Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and BThrombosis and Haemostasis, 2005
- The endogenous thrombin potential and high levels of coagulation factor VIII, factor IX and factor XIBlood Coagulation & Fibrinolysis, 2004
- High Plasma Levels of Factor VIII and the Risk of Recurrent Venous ThromboembolismThe New England Journal of Medicine, 2000